Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects-Reference-Cited by-同舟云学术

Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects

Published:2008-01 Issue:1 Volume:48 Page:85-95
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

He Yan-Ling,Ligueros-Saylan Monica,Sunkara Gangadhar,Sabo Ron,Zhao Charlie,Wang Yibin,Campestrini Joelle,Pommier Françoise,Dole Kiran,Marion Alan,Dole Willia P.,Howard Dan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V;Tarnow;Diabetes Care,1994

2. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial;Stamler;Diabetes Care,1993

3. Blood pressure and end-stage renal disease in men;Klag;N Engl J Med.,1996

4. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial;Brancati;JAMA,1997

5. Diabetes, hypertension, and cardiovascular disease: an update;Sowers;Hypertension,2001

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on the clinical pharmacokinetics of vildagliptin in healthy and disease populations;Expert Opinion on Drug Metabolism & Toxicology;2023-11-26

2. Dipeptidyl Peptidase 4 Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

3. Hypoglycemia Associated With Drug–Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors;Frontiers in Pharmacology;2021-04-15

4. Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence;Hypertension;2021-01

5. Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450;Current Drug Metabolism;2016-07-15